Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Falk

Showing results (261-270 of 279) with videos related to

Pageof 28
Sort By:
Lancet (London, England)|December 26, 2016
An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trialRichard B Warren, Ulrich Mrowietz, Ralph von Kiedrowski, et al.
Transplantation|April 1, 1985
Reversal of cyclosporine-induced mortality with a synthetic polymeric immunostimulant in a murine model of fecal peritonitisF L Moffat, R E Falk, J Teodorczyk-Injeyan, et al.
Transplantation|February 1, 1978
Bone marrow transplantation between a histocompatible parent and child for acute leukemiaP M Falk, P Herzog, R Lubens, et al.
The British Journal of Dermatology|April 12, 2019
Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous T helper 1 and 17 inflammatory pathwaysK Reich, J L K Reich, T M Falk, et al.
Journal of Dentistry|April 2, 2021
Potential of tailored amorphous multiporous calcium silicate glass for pulp capping regenerative endodontics-A preliminary assessmentJie Liu, Chao-An Chen, Xiaofei Zhu, et al.
Circulation Research|June 1, 2002
Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet functionSpencer W Galt, Stephan Lindemann, Loren Allen, et al.
Annals of Hematology|June 1, 1996
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response Modifier (BRM) Study GroupJ Thaler, G Gastl, T Fluckinger, et al.
Diabetes Care|August 27, 2024
Effectiveness of Multilevel and Multidomain Interventions to Improve Glycemic Control in U.S. Racial and Ethnic Minority Populations: A Systematic Review and Meta-analysisEli M Falk, Erin M Staab, Amber N Deckard, et al.
The Journal of Clinical Psychiatry|February 17, 2010
Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitationStephen R Marder, Sebastian Sorsaburu, Eduardo Dunayevich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2015
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analysesP Mitchell, N Thatcher, M A Socinski, et al.
Pageof 28

Showing results (261-270 of 279) with videos related to

Sort By:
Pageof 28
Lancet (London, England)|December 26, 2016
An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trialRichard B Warren, Ulrich Mrowietz, Ralph von Kiedrowski, et al.
Transplantation|April 1, 1985
Reversal of cyclosporine-induced mortality with a synthetic polymeric immunostimulant in a murine model of fecal peritonitisF L Moffat, R E Falk, J Teodorczyk-Injeyan, et al.
Transplantation|February 1, 1978
Bone marrow transplantation between a histocompatible parent and child for acute leukemiaP M Falk, P Herzog, R Lubens, et al.
The British Journal of Dermatology|April 12, 2019
Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous T helper 1 and 17 inflammatory pathwaysK Reich, J L K Reich, T M Falk, et al.
Journal of Dentistry|April 2, 2021
Potential of tailored amorphous multiporous calcium silicate glass for pulp capping regenerative endodontics-A preliminary assessmentJie Liu, Chao-An Chen, Xiaofei Zhu, et al.
Circulation Research|June 1, 2002
Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet functionSpencer W Galt, Stephan Lindemann, Loren Allen, et al.
Annals of Hematology|June 1, 1996
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response Modifier (BRM) Study GroupJ Thaler, G Gastl, T Fluckinger, et al.
Diabetes Care|August 27, 2024
Effectiveness of Multilevel and Multidomain Interventions to Improve Glycemic Control in U.S. Racial and Ethnic Minority Populations: A Systematic Review and Meta-analysisEli M Falk, Erin M Staab, Amber N Deckard, et al.
The Journal of Clinical Psychiatry|February 17, 2010
Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitationStephen R Marder, Sebastian Sorsaburu, Eduardo Dunayevich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2015
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analysesP Mitchell, N Thatcher, M A Socinski, et al.
Pageof 28